News

Pfizer Inc.'s (NYSE:PFE) recent 3.7% pullback adds to one-year year losses, institutional owners may take drastic measures
A look at the shareholders of Pfizer Inc. (NYSE:PFE) can tell us which group is most powerful. The group holding the most ...
Why Apple Is a Great Dividend Stock, Despite Its Low Yield
One "siren's song" that lures in dividend investors all too often is an above-average dividend yield. After all, investors ...
Johnson & Johnson's Healthy 3.3%-Yielding Dividend Is a Very Safe Way to Make Passive Income
The healthcare company's payout currently yields 3.3%, more than double the S&P 500 's ( ^GSPC 0.32%) dividend yield (near a ...
Why Merck Is A Better Dividend Stock Than Gilead Sciences
Merck & Co., Inc. outshines Gilead Sciences, Inc. with stronger dividend growth, valuation metrics & PEGY ratio. Click for ...
Johnson & Johnson's stock surges as tariff cost estimate slashed and profit outlook raised
Shares of Johnson & Johnson climbed 6.8% in morning trading, enough to pace the S&P 500 index's SPX gainers. They were also headed for their biggest one-day gain and best postearnings reaction since ...
Retirement Ready: 3 Dividend Stocks to Set and Forget
These are three rock-solid dividend stocks you can buy now and confidently forget, knowing they’ll keep working for you year ...
Don’t Miss These 4 Stocks With Explosive Dividend Yields
As different stocks rise and fall, so do dividend yields, creating a shifting landscape of opportunities for income-oriented investors. Increases in dividend per share (DPS) greatly allow companies to ...
Building A $100,000 Dividend Portfolio: Maximizing SCHD's Income With July's Top High-Yield Stocks
SCHD underperformed the S&P 500 in 2025 but remains highly attractive due to its strong risk-reward profile and dividend ...